Inventor

Matti Lepistö

Inventor
Lund, SE

Overview

29→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 29 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes20%
C07HSugars9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
Y02ATechnologies for adaptation to climate change8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests8%
PatentTitleYear
10,961,228JAK1 selective inhibitors202110,196,3741-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as SGRM modulators20199,738,632'Phenyl and benzodioxinyl substituted indazoles derivatives'20179,512,110'Phenyl and benzodioxinyl substituted indazoles derivatives'20168,916,600'Phenyl and benzodioxinyl substituted indazoles derivatives'20148,211,930'Phenyl and benzodioxinyl substituted indazoles derivatives'20128,153,673'Metalloproteinase inhibitors'20128,143,290'Chemical compounds 572'20128,030,340'Indazolyl sulphonamide derivatives useful as glucocorticoid modulators'20117,998,984'2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial'20117,754,750'Metalloproteinase inhibitors'20107,728,030'Chemical compounds 572'20107,666,892'Metalloproteinase inhibitors'20107,625,934'Metalloproteinase inhibitors'20097,427,631'Metalloproteinase inhibitors'20087,368,465'Metalloproteinase inhibitors'20087,132,434'Metalloproteinase inhibitors'20067,025,971'Treatment or prophylaxis of diseases caused by pilus-forming bacteria'20066,962,791'Treatment or prophylaxis of diseases caused by pilus-forming bacteria'20056,872,542'Treatment or prophylaxis of diseases caused by pilus-forming bacteria'20056,596,504'Treatment of prophylaxis of diseases caused by pilus-forming bacteria'20036,548,265'Treatment or prophylaxis of diseases caused by pilus-forming bacteria'20036,492,406'Pharmaceutically active compounds'20026,492,409'Kinase inhibitors'20026,420,127'Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections'20026,346,625'Protein kinase inhibitors'20026,337,342'Bis-aryl or heteroaryl indoles'20026,153,396'Treatment or prophylaxis of diseases caused by pilus-forming bacteria'20006,001,823'Treatment or prophylaxis of diseases caused by pilus-forming bacteria'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2016Based in Lund, SE· patent location history
2000–2006Patents assigned to SIGA PHARMACEUTICALS INC (7)· patent assignee history
2000–2005Patents assigned to UNIV WASHINGTON (5)· patent assignee history
2002–2021Patents assigned to ASTRAZENECA AB (21)· patent assignee history
2010–2012Patents assigned to BAYER SCHERING PHARMA AG (4)· patent assignee history
2012–2014Patents assigned to ERIKSSON ANDERS (4)· patent assignee history
2017–2021Based in Molndal, SE· patent location history
2019Based in Mölndal, SE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTRAZENECA AB212002–2021
SIGA PHARMACEUTICALS INC72000–2006
UNIV WASHINGTON52000–2005
BAYER SCHERING PHARMA AG42010–2012
ERIKSSON ANDERS42012–2014
Locations
LocationPatentsSpan
Lund, SE261999–2016
Molndal, SE22017–2021
Mölndal, SE12019